Cholesterol is a type of fat in the blood that the body needs to build cells and produce hormones. However, when cholesterol levels become too high, it can lead to serious health problems such as heart attacks and strokes.
To control this, doctors often prescribe medicines called statins. These drugs help lower cholesterol and reduce the risk of heart disease, and they are widely used around the world.
One of the most commonly used statins is rosuvastatin, also known by its brand name Crestor. It is known for being strong and effective, especially for people who need a larger reduction in cholesterol levels. Because of this, many doctors choose rosuvastatin when patients are at high risk of heart problems.
But new research suggests that this popular drug may not be completely safe for everyone. A recent study from Johns Hopkins University has found that rosuvastatin may increase the risk of kidney problems, especially when taken at higher doses.
The kidneys play an important role in the body. They filter waste from the blood, remove extra fluid, and help keep the body’s chemical balance stable.
When the kidneys are damaged, harmful substances can build up in the body, leading to serious health issues. Early signs of kidney problems often include blood in the urine, known as hematuria, and protein in the urine, called proteinuria. These signs show that the kidneys may not be working properly.
Interestingly, concerns about rosuvastatin and kidney health are not completely new. When the drug was first approved by the U.S. Food and Drug Administration, some reports already suggested possible kidney-related side effects. However, there was not enough long-term research at that time to fully understand the risks.
To investigate further, researchers at Johns Hopkins studied electronic health records from a very large group of patients between 2011 and 2019. They examined data from more than 150,000 people who started taking rosuvastatin. For comparison, they also looked at nearly 800,000 people who began taking another common statin called atorvastatin.
Atorvastatin is also widely used to lower cholesterol and protect heart health. By comparing these two drugs, researchers hoped to see whether rosuvastatin carried any extra risks.
Over a follow-up period of three years, the researchers tracked how often patients developed kidney-related problems. They found that among people taking rosuvastatin, 2.9 percent developed blood in their urine, and 1.0 percent developed protein in their urine.
When compared to patients taking atorvastatin, those on rosuvastatin had an 8 percent higher risk of blood in the urine and a 17 percent higher risk of protein in the urine. Even more concerning, they also had a 15 percent higher chance of developing serious kidney problems that could lead to dialysis or even a kidney transplant.
The risks were even higher for people taking larger doses of rosuvastatin. This is especially worrying for patients who already have kidney disease. In fact, the study found that many patients with poor kidney function were given doses higher than what is recommended. About 44 percent of these patients were taking more than the safe limit suggested by the FDA.
This means that some patients who were already vulnerable may have faced even greater risk because of the higher dose.
The researchers concluded that while rosuvastatin is effective at lowering cholesterol, it appears to carry a greater risk to kidney health compared to atorvastatin. Since both drugs offer similar benefits for protecting the heart, this raises important questions about which drug is the better choice for certain patients.
The study was led by Dr. Jung-im Shin and was published in the Journal of the American Society of Nephrology. The findings highlight the importance of careful decision-making when prescribing cholesterol-lowering drugs.
For patients, this does not mean they should stop taking their medication. Instead, it is a reminder to talk with their doctor about their treatment. Doctors may need to consider lower doses or choose a different statin, especially for patients who already have kidney problems.
In the end, statins like rosuvastatin remain powerful tools for preventing heart disease. But this new research shows that they are not one-size-fits-all solutions. Each patient’s health condition should be carefully considered to ensure the treatment is both safe and effective.
If you care about kidney health, please read studies about how to protect your kidneys from diabetes, and drinking coffee could help reduce risk of kidney injury.
For more information about kidney health, please see recent studies about foods that may prevent recurrence of kidney stones, and eating nuts linked to lower risk of chronic kidney disease and death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
